Rhoen Klinikum (RHK) Given a €25.00 Price Target at Commerzbank

Share on StockTwits

Commerzbank set a €25.00 ($29.07) price objective on Rhoen Klinikum (ETR:RHK) in a research report sent to investors on Friday morning. The firm currently has a neutral rating on the stock.

Other equities analysts have also recently issued reports about the company. Berenberg Bank set a €27.75 ($32.27) target price on Rhoen Klinikum and gave the stock a neutral rating in a report on Monday, August 6th. Warburg Research set a €25.20 ($29.30) target price on Rhoen Klinikum and gave the stock a neutral rating in a report on Friday. Independent Research set a €26.00 ($30.23) target price on Rhoen Klinikum and gave the stock a neutral rating in a report on Wednesday, August 8th. Credit Suisse Group set a €19.00 ($22.09) target price on Rhoen Klinikum and gave the stock a sell rating in a report on Monday, August 6th. Finally, Cfra set a €25.00 ($29.07) target price on Rhoen Klinikum and gave the stock a sell rating in a report on Friday, August 3rd. Five investment analysts have rated the stock with a sell rating and six have issued a hold rating to the stock. The stock presently has an average rating of Hold and a consensus target price of €24.10 ($28.02).

Shares of ETR RHK traded up €0.66 ($0.77) during mid-day trading on Friday, reaching €22.76 ($26.47). The company had a trading volume of 65,823 shares, compared to its average volume of 43,281. Rhoen Klinikum has a 1-year low of €25.08 ($29.16) and a 1-year high of €32.12 ($37.35).

About Rhoen Klinikum

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Story: What are the components of an earnings report?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply